Microcrystalline Cellulose (MCC) Market: Growing Demand, Leading Innovators, and Future Outlook to 2030

The Microcrystalline Cellulose (MCC) market is witnessing steady growth driven by rising demand in food, pharmaceuticals, and personal care industries. Key companies like DuPont, DFE Pharma, Asahi Kasei, and FMC Corporation are focusing on product innovation and regional expansion to meet evolving consumer and industrial needs, shaping a competitive global landscape.

The Microcrystalline Cellulose (MCC) Market is projected to grow from USD 1.33 billion in 2025 to USD 1.88 billion by 2030, at a CAGR of 7.1% during the forecast period. The report includes information on market trends and development, microcrystalline cellulose market growth drivers, emerging technologies, and the investment structure of the market. The market for microcrystalline cellulose is influenced by several primary factors, such as the existence of numerous manufacturers, government support, and increased microcrystalline cellulose production. Due to its exceptional properties such as excellent compressibility and binding capacity, high water-holding capacity and moisture retention makes it an essential material in applications such as pharmaceutical, food & beverage, and cosmetics & personal care. Microcrystalline cellulose exhibits outstanding compressibility, allowing it to form strong, cohesive compacts without the need for binders. This property is essential for tablet formulation in pharmaceuticals, ensuring tablets are robust enough to withstand handling and transportation. Microcrystalline cellulose is chemically inert, non-reactive with other formulation components, and stable under various conditions. It is not digested by the human body, passes through the system as insoluble dietary fiber, and does not contribute calories, making it ideal for low-calorie and dietary fiber-fortified foods.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=59144224

Wood dominated the source segment in terms of value in the microcrystalline cellulose market.

Wood is considered to be the most preferred source for manufacturing microcrystalline cellulose primarily due to its high and consistent cellulose content, established processing methods, and the superior quality of the resulting microcrystalline cellulose. Wood pulp, especially from softwood and hardwood sources, contains a high percentage of alpha cellulose, which is essential for producing microcrystalline cellulose with excellent physical properties such as bulk density, flowability, and compressibility. The cellulose chains in wood are closely packed and held together by strong hydrogen bonds, resulting in a highly crystalline structure that is ideal for microcrystalline cellulose production.

The process of extracting microcrystalline cellulose from wood pulp is well-established and has been refined over more than 70 years, making it both reliable and scalable for industrial production. The Kraft and sulphite pulping methods efficiently remove lignin and hemicellulose, yielding purified cellulose that can be consistently hydrolysed to produce high-quality microcrystalline cellulose.

Microcrystalline cellulose derived from wood exhibits excellent binding and compressibility, which are critical for its primary use as a binder and disintegrant in pharmaceutical tablet formulations. The plasticity and particle structure of wood based microcrystalline cellulose make it particularly effective in direct compression processes.

Pharmaceutical application accounted for the largest share in the application segment in terms of value in the microcrystalline cellulose market.

Pharmaceutical application accounted for the largest share of the global microcrystalline cellulose market in 2024. Microcrystalline cellulose is a key excipient in pharmaceutical tablet and capsule formulations. Its excellent binding, compressibility, and disintegration properties make it indispensable for producing tablets with uniform drug distribution, consistent release profiles, and reliable mechanical strength. Microcrystalline cellulose is used in a wide range of pharmaceutical products, including quick-release tablets, sustained-release multiparticulates, matrix tablets, chewable, and effervescent tablets. Its ability to function as a binder, filler, and disintegrant enhances the efficiency and quality of drug delivery systems. Microcrystalline cellulose meets stringent regulatory requirements for safety, efficacy, and quality, making it the preferred choice for pharmaceutical manufacturers worldwide. Regulatory bodies such as the FDA and EMA recognize microcrystalline cellulose as a safe and effective excipient, further driving its adoption.

Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=59144224

North America accounted for the largest share of the microcrystalline cellulose market in terms of value and volume.

North America accounted for the largest share of the microcrystalline cellulose market with the US leading the market in the region. The growth in the microcrystalline cellulose market in this region is driven mainly by its use in pharmaceutical excipients, food & beverage, and cosmetic & personal care industries. The pharmaceutical application accounted for the maximum market share in the North American microcrystalline cellulose market, in terms of value, in 2024. The largest share of the application in the North American microcrystalline cellulose market is mainly attributed to the presence of a large number of global pharmaceutical giants, such as Pfizer (US), Abbott Laboratories (US), and Johnson & Johnson (US), in this region.

Microcrystalline Cellulose Companies

Prominent companies include Asahi Kasei Corporation (Japan), Rayonier Advanced Materials (RYAM, US), Sigachi Industries (India), DFE Pharma (Germany), International Flavors & Fragrances Inc. (New York), Accent Microcell Ltd. (India), Mingtai Chemical Co., Ltd. (China), Chemfield Cellulose (India), Anhui Sunhere Pharmaceutical Excipients Co., Ltd. (China), Roquette Freres (France), J. Rettenmaier & Sohne GmbH + Co. Kg (JRS Pharma, Germany), RanQ (India), and Huzhou City Linghu Xinwang Chemical Co., Ltd. (China).

Asahi Kasei Corporation (Japan)

Asahi Kasei Corporation is involved in manufacturing organic and inorganic industrial chemicals, polymers, performance materials, petrochemicals, and other consumer products. The company operates through three main segments: material, homes, and healthcare. Asahi supplies microcrystalline cellulose through its healthcare segment. The company’s operating bases are strategically located around the world to ensure efficient supply of products and services in North America, Europe, and Asia Pacific.

International Flavors & Fragrances Inc. (US)

International Flavors & Fragrances Inc. (IFF) is a leading global company that specializes in manufacturing and distributing flavors, fragrances, and ingredients for various industries, including food, beverages, health, biosciences, and pharmaceuticals. The company has four reportable segments: Nourish, Health & Biosciences, Scent, and Pharma Solutions. International Flavors & Fragrances Inc. offers microcrystalline cellulose through its Pharma Solutions segment.

The group operates in 65 countries, with a diverse presence across Asia Pacific, Europe, the Middle East & Africa, North America, and South America. IFF maintains over 100 research & development centres globally, supporting innovation and customer collaboration.

Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=59144224

Roquette Freres (France)

Roquette Freres is a global leader in plant-based ingredients and a top provider of pharmaceutical excipients. Working with its customers and partners, the group tackles current and future societal challenges by harnessing nature’s potential to deliver the best ingredients for food, nutrition, and health markets. The company conducts its business through two main reportable segments: Pharma Solutions and Key Ingredients, with microcrystalline cellulose products marketed under the pharma solutions division segment.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/microcrystalline-cellulose-market-59144224.html